Veradigm (NASDAQ:MDRX) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX) in a research report released on Wednesday morning. The firm issued a hold rating on the software maker’s stock.

MDRX has been the subject of several other reports. TD Cowen lowered their price objective on shares of Veradigm from $26.00 to $15.00 and set a buy rating for the company in a research report on Tuesday, May 28th. Deutsche Bank Aktiengesellschaft restated a hold rating and set a $10.00 price objective (down from $15.00) on shares of Veradigm in a research report on Tuesday, March 19th. Five analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of Hold and an average price target of $12.00.

Veradigm Trading Up 5.6 %

NASDAQ MDRX opened at $9.50 on Wednesday. Veradigm has a 1-year low of $5.01 and a 1-year high of $14.09. The company has a 50 day moving average of $8.57 and a 200-day moving average of $8.64.

Institutional Trading of Veradigm

Several hedge funds and other institutional investors have recently modified their holdings of the business. TFO Wealth Partners LLC grew its stake in Veradigm by 105,280.0% in the 4th quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock worth $52,000 after buying an additional 5,264 shares in the last quarter. Gladius Capital Management LP grew its stake in Veradigm by 135.0% in the 4th quarter. Gladius Capital Management LP now owns 6,245 shares of the software maker’s stock worth $66,000 after buying an additional 3,587 shares in the last quarter. Meadow Creek Wealth Advisors LLC purchased a new position in Veradigm in the 1st quarter worth approximately $83,000. Headlands Technologies LLC grew its stake in Veradigm by 14,907.7% in the 4th quarter. Headlands Technologies LLC now owns 9,755 shares of the software maker’s stock worth $102,000 after buying an additional 9,690 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new position in Veradigm in the 3rd quarter worth approximately $189,000.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.